241 related articles for article (PubMed ID: 21953648)
1. Ten-year survival of esophageal cancer after an en-bloc esophagectomy.
Oezcelik A; Kaiser GM; Niebel W; Sleyman C; Treckmann JW; Sotiropoulos GC; Reinhardt R; Trarbach T; Malamutmann E; Paul A
J Surg Oncol; 2012 Mar; 105(3):284-7. PubMed ID: 21953648
[TBL] [Abstract][Full Text] [Related]
2. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
4. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.
Hagen JA; Peters JH; DeMeester TR
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):850-8; discussion 858-9. PubMed ID: 8231207
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
6. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
[TBL] [Abstract][Full Text] [Related]
7. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
[TBL] [Abstract][Full Text] [Related]
8. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
9. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
10. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
[TBL] [Abstract][Full Text] [Related]
12. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma.
Singh RK; Pham TH; Diggs BS; Perkins S; Hunter JG
Arch Surg; 2011 Jun; 146(6):711-4. PubMed ID: 21690448
[TBL] [Abstract][Full Text] [Related]
13. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
[TBL] [Abstract][Full Text] [Related]
14. Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centers?
Hanna GB; Boshier PR; Knaggs A; Goldin R; Sasako M
Arch Surg; 2012 Aug; 147(8):738-45. PubMed ID: 22911070
[TBL] [Abstract][Full Text] [Related]
15. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
16. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
18. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?
Hu Y; Hu C; Zhang H; Ping Y; Chen LQ
Ann Surg Oncol; 2010 Mar; 17(3):784-90. PubMed ID: 19953333
[TBL] [Abstract][Full Text] [Related]
19. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer.
Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
Eur J Cardiothorac Surg; 2007 Feb; 31(2):154-60. PubMed ID: 17145185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
